I provide independent and original analysis, pricing metrics and recommendations for the stem, cell, gene and regenerative therapy equities.

My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.

My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.

Do you have an opinion you would like to share with us? We would like to hear from you.

  Please e-mail us at hwm@regmedinvestors.com.

Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors with past experience in sell-side analysis, buy-side management, corporate management and due diligence.